Abstract
The UDP-glucose 4-epimerase (GALE) is a glycosyltransferase, which acts on protein and lipid glycosylation in normal and neoplastic cells. This study is aimed at investigating the differential tissue expression of GALE and its possible association with clinical-pathological parameters and the outcome of gastric adenocarcinoma patients. Seventy-one patients were evaluated in relation to GALE expression by immunohistochemistry. Our results showed that 48 (67.6%) patients were GALE positive and 23 (32.4%) negative. Positive staining was present on well-differentiated and moderate-differentiated histological grade of gastric adenocarcinomas (p<0.0001). There was no significant association with outcome parameters (p>0.05). Besides that, our results corroborated with the validation cohort analysis, where the expression of GALE mRNA was also associated with the histological grade (p<0.001). These results suggest a possible use of this enzyme as a biomarker for well and moderately differentiated tumors.
Cite
CITATION STYLE
De Souza, M. D. F. D., Da Silva Filho, A. F., De Barros Albuquerque, A. P., Quirino, M. W. L., De Souza Albuquerque, M. S., Cordeiro, M. F., … De Melo Rêgo, M. J. B. (2019). Overexpression of UDP-Glucose 4-Epimerase Is Associated with Differentiation Grade of Gastric Cancer. Disease Markers, 2019. https://doi.org/10.1155/2019/6325326
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.